Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$122M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$89.5M |
| 3 |
Microsoft
MSFT
|
+$71.3M |
| 4 |
Visa
V
|
+$67M |
| 5 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$61.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$277M |
| 2 |
Micron Technology
MU
|
+$59M |
| 3 |
TCN
Tricon Residential Inc.
TCN
|
+$55.8M |
| 4 |
Zoetis
ZTS
|
+$48.4M |
| 5 |
Amgen
AMGN
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.69% |
| 2 | Industrials | 5.51% |
| 3 | Financials | 5.39% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Healthcare | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNCR
2051
DELISTED
Synchronoss Technologies
SNCR
| $269K | ﹤0.01% |
28,916
| – | – |
|
2052
CALL
Edwards Lifesciences
EW
$52.2B
| $268K | ﹤0.01% |
+2,900
| New | +$257K |
|
2053
CALL
S&P Global
SPGI
$128B
| $268K | ﹤0.01% |
600
-600
| -50% | -$257K |
|
2054
Fortinet
FTNT
$112B
| $267K | ﹤0.01% |
4,423
-124,572
| -97% | -$7.75M |
|
2055
CALL
Advance Auto Parts
AAP
$2.63B
| $266K | ﹤0.01% |
4,200
-900
| -18% | -$64.4K |
|
2056
CALL
Flex
FLEX
$39.4B
| $265K | ﹤0.01% |
+9,000
| New | +$269K |
|
2057
Replimune Group
REPL
$1.39B
| $264K | ﹤0.01% |
29,373
+17,152
| +140% | +$120K |
|
2058
CALL
Ambarella
AMBA
$3.07B
| $264K | ﹤0.01% |
+4,900
| New | +$243K |
|
2059
CALL
Wolfspeed
WOLF
$1.29B
| $264K | ﹤0.01% |
11,600
-30,200
| -72% | -$781K |
|
2060
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42B
| $264K | ﹤0.01% |
+7,514
| New | +$267K |
|
2061
iShares MSCI ACWI ex US ETF
ACWX
$12.4B
| $263K | ﹤0.01% |
+4,959
| New | +$264K |
|
2062
Camtek
CAMT
$6.64B
| $263K | ﹤0.01% |
+2,103
| New | +$201K |
|
2063
CALL
Automatic Data Processing
ADP
$112B
| $263K | ﹤0.01% |
1,100
-8,400
| -88% | -$2.06M |
|
2064
CALL
Woodward
WWD
$19.7B
| $262K | ﹤0.01% |
+1,500
| New | +$255K |
|
2065
Inogen
INGN
$146M
| $261K | ﹤0.01% |
32,147
-49,430
| -61% | -$383K |
|
2066
Manitowoc
MTW
$710M
| $261K | ﹤0.01% |
22,612
-29,617
| -57% | -$366K |
|
2067
PUT
Zimmer Biomet
ZBH
$19.3B
| $260K | ﹤0.01% |
+2,400
| New | +$283K |
|
2068
iShares Preferred and Income Securities ETF
PFF
$13.1B
| $259K | ﹤0.01% |
8,224
-4,219
| -34% | -$133K |
|
|
DFAI
2069
Dimensional International Core Equity Market ETF
DFAI
$18.2B
| $257K | ﹤0.01% |
+8,653
| New | +$260K |
|
|
HLVX
2070
DELISTED
HilleVax
HLVX
| $256K | ﹤0.01% |
17,724
| – | – |
|
2071
First Trust Value Line Dividend Fund
FVD
$8.35B
| $254K | ﹤0.01% |
6,240
-630
| -9% | -$26K |
|
2072
Dimensional US Core Equity 2 ETF
DFAC
$49.2B
| $253K | ﹤0.01% |
+7,862
| New | +$248K |
|
2073
PUT
Parker-Hannifin
PH
$128B
| $253K | ﹤0.01% |
+500
| New | +$268K |
|
2074
PUT
Diageo
DEO
$53.4B
| $252K | ﹤0.01% |
2,000
+500
| +33% | +$68.9K |
|
2075
Mercer International
MERC
$26.9M
| $251K | ﹤0.01% |
+29,421
| New | +$284K |
|
Similar funds
Paul Tudor Jones's Q2 2024 Portfolio in Review
As of Q2 2024, Paul Tudor Jones held 2,929 positions worth $19.5B, up 24% from $15.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Paul Tudor Jones deployed $4.18B of net new capital in Q2 2024, opening 786 new positions and adding to 755 existing holdings. Its largest new stake was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 8.9% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $59M trimmed.
- Paul Tudor Jones's largest Q2 2024 buy was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
- Paul Tudor Jones added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $122M increase.
- Paul Tudor Jones's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $59M.
- Paul Tudor Jones fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $277M.
- Paul Tudor Jones's ten largest holdings make up 34% of its $19.5B portfolio in Q2 2024.
- Paul Tudor Jones opened 786 new positions and closed 671 in Q2 2024.
- Paul Tudor Jones's portfolio value rose 24% quarter-over-quarter to $19.5B.
Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.